Scientific journal
European Journal of Natural History
ISSN 2073-4972


Primak T.D., Erdyneeva B.S., Shevchuk Eu.A., Kalinina S.V.

The aim of the investigation was to study Staphylococcus aureus carrier state on the upper respiratory mucous membrane among healthy population and to develop a new method of its correction.

Material and methods.  Bacterial status was studied in 1600 healthy subjects of reproductive age, with 192 cases being registered to carry Staphylococcus aureus on their upper respiratory mucus. Comparison group composed 60 patients - Staphylococcus aureus carriers    who were treated by probiotics in combination with aeroiontherapy. Nasopharyngeal microflora was studied by the conventional bacteriological method.

Results. 12% healthy subjects proved to be Staphylococcus aureus carriers.  Pathogenic staphylococci were revealed in all the subjects examined.

The available methods of treating the rhinopharynx are numerous, though not always efficient and harmless (Onishchenko G.G.).  The method we suggest implies administration of an enzyme probiotic having an antibacterial effect in combination with a flow of negative air ions inhaled 20 minutes daily over a period of 10 days. "Balance-naryne-F" which contains products of acidophilus lactobacillus activity was used as an enzyme probiotic with an antibacterial effect against a number of pathogenic microorganisms. Aeroionificator "Spherion" was used as a source of negative air ions flow. "Balance-naryne-F" is absolutely harmless, has no contraindications and is well tolerated.   The everyday apparatus "Spherion" helps stabilize redox processes in respiratory cells; it yields a flow of negative air ions amounting up to 1000 units per 1 ml air (Hygiene Rules, 2003).  In the course of the study 60 subjects were treated by the new method, with Staphylococci recurrence rate being registered only in 2 cases (3%), without any allergic reactions or any other complications.

Conclusions. The method suggested for treating bacterial carrier states allows to exclude any pathogenic staphylococci in respiratory discharge in 97 % cases, as well as to prevent any possible complications in the subjects suspected to be bacterial carriers.

The article is admitted to the V Scientific Conference «Present-day problems of experimental and clinical medicine », Thailand, February 20-28, 2008, came to the editorial office on 26.11.07